Company Filing History:
2 out of 818 
2 out of 757 
2 out of 61 
Years Active: 2019
Title: Innovations in Cancer Therapeutics by Jennifer Schlezinger
Introduction
Jennifer Schlezinger is an accomplished inventor based in East Falmouth, MA (US). She has made significant contributions to the field of cancer therapeutics, holding 2 patents that focus on novel agents for cancer treatment. Her work aims to inhibit cancer cell proliferation and metastasis, showcasing her dedication to advancing medical science.
Latest Patents
Jennifer's latest patents include innovative agents that modulate the aryl hydrocarbon receptor (AhR) activity. These agents are designed for use in therapeutic compositions and methods to inhibit cancer cell proliferation and tumor cell invasion. The patents detail AhR inhibitors or non-constitutive AhR agonists of specific formulas, which are crucial for inhibiting cancer cell growth and addressing parameters that characterize tumor metastasis, such as tumor cell invasiveness.
Career Highlights
Throughout her career, Jennifer has worked with prestigious institutions, including Boston University and Northeastern University. Her research has been pivotal in developing new therapeutic strategies for cancer treatment.
Collaborations
Jennifer has collaborated with notable professionals in her field, including David H. Sherr and Michael Pollastri. These collaborations have further enriched her research and contributed to her innovative work in cancer therapeutics.
Conclusion
Jennifer Schlezinger's contributions to cancer therapeutics through her patents and collaborations highlight her role as a leading inventor in the field. Her innovative approaches continue to inspire advancements in cancer treatment.